Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston/Johnson & Johnson get June 05 patent trial date

This article was originally published in Clinica

Executive Summary

The US District Court in Delaware has scheduled a trial for June 2005 in the ongoing drug-eluting stent patent infringement battle between Boston Scientific and Johnson & Johnson unit Cordis. The trial will not address all of the patents cited in the suits that the two firms filed against each other in 2003. It will involve two of the six patents that Boston claims are infringed by Cordis's Cypher sirolimus-coated stent, and the one patent that Cordis claims Boston's Express2 device infringes. Express2 is used as the platform for Boston's Taxus paclitaxel-coated stent.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057226

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel